The rates of injury frequency and severity has either remained stagnant or worsened over the past year, according to Benchmark Gensuite’s 2025 EHS Benchmarking report. The survey found that over half ...
Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast ...
PFHO significantly reduced DED symptoms' severity and frequency within 14 days, with a 62% to 75% reduction in severity. Participants reported increased satisfaction with PFHO, describing it as silky, ...
Randomized Controlled Trial of Impact of Mobile Health Technologies on Human Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos, Nigeria (mHealth-HPVac) The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results